Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketoconazole and Trem2 in Cryptorchidism Mechanism
NCT06560086Recruiting
- Sponsor
- Affiliated Hospital of Nantong University
- Start
- Feb 2024
- Primary completion
- Dec 2024
- Countries
- 1
01
Overview
Open-label trial (3 arms), sponsored by Affiliated Hospital of Nantong University. Primary endpoint: Relative expression of Trem2 and insulin-like 3 protein at 14 days. Started Feb 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06560086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06560086.